Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced data from a poster ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...

Is AI becoming commoditized? Explore how Gemini 2.5, DeepSeek V3, and Microsoft-OpenAI rivalry are reshaping the future of ...

The Good Bug cofounder Keshav Biyani believes that platforms like Startup Mahakumbh will help shape the future of health and ...

Texas' measles outbreak has brought renewed attention to the state's politically chared vaccine debate. Here's how elected ...

Continental showcases sustainable tire technology and innovations in wear analysis and bonding systems at Tire Technology ...

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” fourth quarter 2024 investor ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

Hospitals’ increased reliance on agency nurses and overtime shifts for in-house nurses appears to have implications for ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.